{
  "id": "mhgap#management_15ea3f5d",
  "content": "Atkinson LZ, Ogawa Y et al. Comparative efficacy cognitive behavioral therapy for depression:\nand acceptability of 21 antidepressant drugs a systematic review and individual patient\nfor the acute treatment of adults with major data network meta-analysis. JAMA Psychiatry.\ndepressive disorder: a systematic review and 2021;78(4):361–71 (https://doi.org/10.1001/\nnetwork meta-analysis. Focus. 2018;16(4):420–9 jamapsychiatry.2020.4364).\n(https://doi.org/10.1176/appi.focus.16407).\n131. Mental health systems in selected low- and\nmiddle-income countries: a WHO-AIMS cross-\nnational analysis. Geneva: World Health\nOrganization; 2009 (https://iris.who.int/\nhandle/10665/44151).\n123\nMental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders\n139. Karyotaki E, Araya R, Kessler RC, Waqas A, 146. The health and social effects of nonmedical\nBhana A, Rahman A et al. Association of task- cannabis use. Geneva: World Health Organization;\nshared psychological interventions with 2016 (https://iris.who.int/handle/10665/251056).\ndepression outcomes in low- and middle-income\n147. World Health Organization, United Nations Office\ncountries: a systematic review and individual\non Drugs and Crime. International standards\npatient data meta-analysis. JAMA Psychiatry.\nfor the treatment of drug use disorders: revised\n2022;79(5):430–43 (https://doi.org/10.1001/\nedition incorporating results of field-testing.\njamapsychiatry.2022.0301).\nGeneva: World Health Organization; 2020 (https://\n140. Cuijpers P, Noma H, Karyotaki E, Vinkers CH, apps.who.int/iris/handle/10665/331635).\nCipriani A, Furukawa TA. A network meta-\n148. Tardelli VS, Bisaga A, Arcadepani FB, Gerra G, Levin",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "study",
      "work",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Management Atkinson LZ, Ogawa Y et al. Comparative efficacy cognitive behavioral therapy for depression:\nand acceptability of 21 antidepressant drugs a systematic review and individual patient\nfor the acute treatment of adults with major data network meta-analysis. JAMA Psychiatry.\ndepressive disorder: a systematic review and 2021;78(4):361–71 (https://doi.org/10.1001/\nnetwork meta-analysis. Focus. 2018;16(4):420–9 jamapsychiatry.2020.4364).\n(https://doi.org/10.1176/appi.focus.16407).\n131. Mental health systems in selected low- and\nmiddle-income countries: a WHO-AIMS cross-\nnational analysis. Geneva: World Health\nOrganization; 2009 (https://iris.who.int/\nhandle/10665/44151).\n123\nMental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders\n139. Karyotaki E, Araya R, Kessler RC, Waqas A, 146. The health and social effects of nonmedical\nBhana A, Rahman A et al. Association of task- cannabis use. Geneva: World Health Organization;\nshared psychological interventions with 2016 (https://iris.who.int/handle/10665/251056).\ndepression outcomes in low- and middle-income\n147. World Health Organization, United Nations Office\ncountries: a systematic review and individual\non Drugs and Crime. International standards\npatient data meta-analysis. JAMA Psychiatry.\nfor the treatment of drug use disorders: revised\n2022;79(5):430–43 (https://doi.org/10.1001/\nedition incorporating results of field-testing.\njamapsychiatry.2022.0301).\nGeneva: World Health Organization; 2020 (https://\n140. Cuijpers P, Noma H, Karyotaki E, Vinkers CH, apps.who.int/iris/handle/10665/331635).\nCipriani A, Furukawa TA. A network meta-\n148. Tardelli VS, Bisaga A, Arcadepani FB, Gerra G, Levin Atkinson lz, ogawa y et al. comparative efficacy cognitive behavioral therapy for trầm cảm:\nand acceptability of 21 antidepressant drugs a systematic review and individual patient\nfor the acute treatment of adults with m..."
}